Product Description
Erythropoietin (EPO) is a vital glycoprotein hormone primarily produced by the kidneys that plays a crucial role in regulating red blood cell production (erythropoiesis). Our Recombinant Human Erythropoietin is a highly purified protein that mimics the biological activity of endogenous EPO. It acts on erythroid progenitor cells in the bone marrow to stimulate proliferation, differentiation, and survival, thereby enhancing the oxygen-carrying capacity of the blood. Beyond its classic hematopoietic functions, EPO also exhibits significant tissue-protective, anti-inflammatory, and anti-apoptotic properties in non-erythropoietic tissues, including the central nervous and cardiovascular systems.
Product Benefits
Recombinant EPO is a cornerstone in both clinical therapeutics and advanced biomedical research, offering profound benefits in hematological and non-hematological applications:
Anemia Management: EPO is extensively used to stimulate red blood cell production, providing critical support for patients suffering from anemia associated with chronic kidney disease (CKD) or induced by cancer chemotherapy and antiretroviral treatments.
Neuroprotection and Tissue Repair: Emerging research highlights EPO’s non-hematopoietic benefits. It promotes the survival of endothelial cells and neurons, offering potential protective effects against ischemic-reperfusion injury, myocardial infarction, and neurodegenerative conditions.
Biomedical Research & Diagnostics: As a premium-grade recombinant protein, it serves as an excellent immunogen, positive control for ELISA/Western Blot, and a vital supplement for in vitro erythroid cell culture, stem cell differentiation, and drug screening studies.